109 related articles for article (PubMed ID: 27530921)
1. O-GlcNAcylation of the Signaling Scaffold Protein, GNB2L1 Promotes its Degradation and Increases Metastasis of Gastric Tumours.
Cheng S; Ren J; Su L; Liu J; Liu Q; Zhou J; Ye X; Zhu N
Biochem Biophys Res Commun; 2016 Sep; 478(4):1497-502. PubMed ID: 27530921
[TBL] [Abstract][Full Text] [Related]
2. GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.
Cheng S; Mao Q; Dong Y; Ren J; Su L; Liu J; Liu Q; Zhou J; Ye X; Zheng S; Zhu N
PLoS One; 2017; 12(8):e0182696. PubMed ID: 28797110
[TBL] [Abstract][Full Text] [Related]
3. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
4. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.
Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M
Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751
[TBL] [Abstract][Full Text] [Related]
6. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
8. miR-483 is down-regulated in gastric cancer and suppresses cell proliferation, invasion and protein O-GlcNAcylation by targeting OGT.
Yu FY; Zhou CY; Liu YB; Wang B; Mao L; Li Y
Neoplasma; 2018 Mar; 65(3):406-414. PubMed ID: 29788742
[TBL] [Abstract][Full Text] [Related]
9. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
Jiang M; Xu B; Li X; Shang Y; Chu Y; Wang W; Chen D; Wu N; Hu S; Zhang S; Li M; Wu K; Yang X; Liang J; Nie Y; Fan D
Oncogene; 2019 Jan; 38(3):301-316. PubMed ID: 30093632
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.
Jiang M; Wu N; Xu B; Chu Y; Li X; Su S; Chen D; Li W; Shi Y; Gao X; Zhang H; Zhang Z; Du W; Nie Y; Liang J; Fan D
Theranostics; 2019; 9(18):5359-5373. PubMed ID: 31410220
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
[TBL] [Abstract][Full Text] [Related]
13. A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells.
Jin FZ; Yu C; Zhao DZ; Wu MJ; Yang Z
Exp Cell Res; 2013 Jun; 319(10):1482-90. PubMed ID: 23524144
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation-mediated degradation of FBXL2 stabilizes FOXM1 to induce cancer progression.
Ueda Y; Moriwaki K; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2020 Jan; 521(3):632-638. PubMed ID: 31679690
[TBL] [Abstract][Full Text] [Related]
16. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
17. Silencing β-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
Wen T; Hou K; Li Z; Li L; Yu H; Liu Y; Li Y; Yin Z
Oncol Rep; 2015 Dec; 34(6):3140-6. PubMed ID: 26397041
[TBL] [Abstract][Full Text] [Related]
18. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
[TBL] [Abstract][Full Text] [Related]
20. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
